Healthy Inc > Blog > B2B pharma marketplace
Posted on:

What is Lisinopril 2.5 mg used for?

In the pharmaceutical industry, Lisinopril 2.5 mg is an ACE (Angiotensin-Converting Enzyme) Inhibitor. As a pharmacist, I view the 2.5 mg strength as the critical “initiation dose.” It is used to carefully start treatment in patients who may be sensitive to blood pressure changes, such as the elderly or those on high-dose diuretics, to avoid a sudden drop in blood pressure (first-dose hypotension).

Primary Clinical Uses

  • Hypertension (High Blood Pressure): Used as a starting dose to gradually lower blood pressure. It is often titrated upward to 10 mg or 20 mg for long-term maintenance.

  • Heart Failure: Administered as an adjunctive therapy to improve survival and reduce hospitalizations by easing the workload on the heart.

  • Post-Myocardial Infarction (Heart Attack): Given within 24 hours of a heart attack to improve hemodynamics and prevent the heart muscle from weakening (remodeling).

  • Diabetic Nephropathy: Prescribed to protect kidney function in diabetic patients by reducing the pressure in the small blood vessels of the kidneys.

Mechanism of Action: The RAAS Pathway

Lisinopril belongs to the dicarboxylic acid-containing group of ACE inhibitors. Unlike many others, it is not a prodrug and does not require liver metabolism to become active.

Enzyme Blockade: It inhibits the enzyme responsible for converting Angiotensin I into Angiotensin II (a powerful vasoconstrictor).

Vasodilation: By reducing Angiotensin II, it allows the blood vessels to relax and widen.

Aldosterone Reduction: It lowers the secretion of aldosterone, which decreases sodium and water retention, thereby reducing the total blood volume.

Kidney Protection: It specifically dilates the efferent arteriole in the kidney, lowering intraglomerular pressure.

The Manufacturer’s Perspective: Technical & Export

From a manufacturing standpoint in a WHO-GMP facility, Lisinopril 2.5 mg presents specific professional requirements:

  • Content Uniformity: Achieving a precise 2.5 mg distribution in a standard-sized tablet requires high-precision blending and validated geometric dilution to ensure every tablet in a batch is therapeutically identical.

  • Stability & Sensitivity: Lisinopril is sensitive to moisture and can undergo cyclization to form diketopiperazine. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • Bioequivalence: As a manufacturer, we provide dissolution profiles comparing our generic to the innovator (Zestril or Prinivil) to ensure B2B buyers of its efficacy.

  • Dossier Availability: Our Mumbai facility maintains full CTD/eCTD Dossiers to support rapid product registration in international markets.

Lisinopril Tablets

Posted on:

What is Linezolid 600 mg used for?

In the pharmaceutical industry, Linezolid 600 mg is a powerhouse oxazolidinone antibiotic. As a pharmacist and manufacturer, I view Linezolid as a “reserve” or “last-resort” antibiotic. It is specifically designed to combat some of the most difficult-to-treat, multi-drug-resistant Gram-positive bacteria that have become immune to standard treatments like penicillins and cephalosporins.

Primary Clinical Uses

  • VRE Infections: Treatment of infections caused by Vancomycin-resistant Enterococcus faecium.

  • MRSA (Methicillin-resistant Staphylococcus aureus): Used for nosocomial (hospital-acquired) pneumonia and complicated skin/soft tissue infections caused by MRSA.

  • Drug-Resistant Tuberculosis (MDR-TB): Linezolid is increasingly used as a core component of “Group B” drugs for the treatment of multi-drug-resistant tuberculosis.

  • Complicated Skin and Skin Structure Infections (cSSSI): Effective against diabetic foot infections and severe cellulitis involving resistant strains.

Mechanism of Action: Inhibiting the 50S Ribosome

Linezolid has a unique mechanism that differentiates it from other protein synthesis inhibitors (like macrolides or tetracyclines).

Unique Binding Site: It binds to the 23S ribosomal RNA of the 50S subunit.

Inhibition of Initiation: It prevents the formation of the 70S initiation complex, which is the essential “starting point” for bacterial protein synthesis.

Prevention of Resistance: Because it acts so early in the translation process, there is very little cross-resistance with other antibiotic classes, making it effective when others fail.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Linezolid 600 mg is a high-value, high-precision product:

  • Bioavailability (USP): Linezolid has nearly 100% oral bioavailability. This means the 600 mg oral dose is clinically equivalent to the intravenous (IV) dose, allowing patients to be switched from hospital IV to home oral therapy easily—a major selling point for B2B buyers.

  • Light Sensitivity: Linezolid is highly sensitive to light (photolabile). As a WHO-GMP manufacturer, we ensure the tablets are protected using opaque Alu-Alu or Amber-colored PVC/PVDC blister packaging to ensure a 36-month shelf life.

  • Polymorphism: Control of the crystalline Form II is critical for ensuring the stability and dissolution of the 600 mg tablet according to BP/USP/IP standards.

  • B2B & Institutional Tenders: This is a vital product for specialized hospitals and TB control programs. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Zyvox).

Linezolide Tablets

Posted on:

What are Levothyroxine sodium tablets used for?

In the pharmaceutical industry, Levothyroxine Sodium is a synthetic form of the endogenous hormone thyroxine (). As a pharmacist and manufacturer, I view this as a “narrow therapeutic index” (NTI) drug, meaning even slight variations in dosage or bioavailability can significantly affect a patient’s health. It is a foundational product in endocrinology.

Primary Clinical Uses

  • Hypothyroidism: The primary indication for replacement therapy in patients with primary (thyroidal), secondary (pituitary), or tertiary (hypothalamic) hypothyroidism.

  • Congenital Hypothyroidism: Essential for infants to prevent developmental delays and cretinism.

  • Pituitary TSH Suppression: Used in the management of thyroid cancer and goiters to suppress the secretion of Thyroid Stimulating Hormone (TSH).

  • Myxedema Coma: The injectable form is used for this severe, life-threatening manifestation of hypothyroidism.

Mechanism of Action: Replacing 

Levothyroxine acts exactly like the natural hormone produced by the thyroid gland.

Conversion to : Once ingested, Levothyroxine () is converted by the liver and kidneys into the more active hormone, triiodothyronine ().

Metabolic Regulation:  enters the cell nuclei and binds to thyroid hormone receptors, which then regulate gene expression responsible for basal metabolic rate, protein synthesis, and sensitivity to catecholamines.

Homeostasis: This restores normal energy levels, heart rate, and temperature regulation in the body.

The Manufacturer’s Perspective: Precision & Stability

From a manufacturing and global trade standpoint, Levothyroxine is one of the most technically demanding tablets to produce:

  • Potency & Uniformity: Because doses are micro-measured (e.g., 25 mcg, 50 mcg, 100 mcg), achieving 100% content uniformity is critical. As a WHO-GMP manufacturer, we utilize validated micronization and specialized blending equipment to ensure every tablet has the exact micro-dose required.

  • Stability (The 95-105% Rule): Levothyroxine is highly sensitive to light, moisture, and temperature. Regulatory bodies often require a stricter potency range over the shelf life. At our Mumbai facility, we use Alu-Alu blister packaging to ensure a 24-month shelf life for export to Zone IVb regions.

  • Bioequivalence: Even small changes in excipients can alter absorption. We provide full CTD/eCTD Dossiers and dissolution studies to ensure our generic is bioequivalent to the innovator (Synthroid or Eltroxin).

    B2B Branding: For your digital platform, it is important to note that patients often stay on the same brand of Levothyroxine for years due to the NTI nature of the drug, making it a high-loyalty product for your trading firm.

 

Levothyroxine Tablets

Posted on:

What is Levofloxacin 750mg used for?

In the pharmaceutical industry, Levofloxacin 750 mg is a high-potency, third-generation fluoroquinolone antibiotic. As a pharmacist and manufacturer, I view the 750 mg strength as the “intensive care” oral dose. It is designed to achieve high peak plasma concentrations (), allowing for a shorter, more aggressive treatment course (typically 5 days) compared to the traditional 10–14 day regimens of lower strengths.

Primary Clinical Uses

  • Pneumonia: Highly effective against both community-acquired pneumonia (CAP) and healthcare-associated pneumonia, including “atypical” pathogens.

  • Acute Bacterial Sinusitis: Used when first-line antibiotics have failed or when the infection is particularly severe.

  • Complicated Urinary Tract Infections (cUTI): Including acute pyelonephritis (kidney infection).

  • Skin and Soft Tissue Infections: Indicated for complicated infections where deep tissue penetration is required.

  • Chronic Bacterial Prostatitis: Levofloxacin is preferred here due to its excellent penetration into prostatic fluid.

Mechanism of Action: DNA Fragmentation

Levofloxacin is a bactericidal agent that disrupts the vital machinery of the bacterial cell.

Enzyme Inhibition: It targets two essential enzymes: DNA gyrase (Topoisomerase II) and Topoisomerase IV.

Supercoiling Disruption: These enzymes are responsible for uncoiling and re-sealing bacterial DNA during replication. By blocking them, Levofloxacin causes the DNA strands to break.

Cell Death: The bacteria can no longer replicate its genetic material or synthesize proteins, leading to rapid cell death.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Levofloxacin 750 mg is a technically demanding product:

  • Pharmacokinetics (): The 750 mg dose is specifically formulated to be “concentration-dependent.” As a firm owner, you should know that achieving bioequivalence against the innovator (Levaquin) requires precise control over the dissolution rate to ensure rapid absorption.

  • Photosensitivity: Levofloxacin is sensitive to light. At our WHO-GMP facility, we utilize opaque PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb regions.

  • Dossier & Regulatory Support: This is a high-value antibiotic for hospital supply. We provide full CTD/eCTD Dossiers to support international registration and B2B tender participation.

  • Safety Monitoring: As a pharmacist, you must ensure your labeling includes the FDA “Black Box Warning” regarding tendonitis and tendon rupture, which is a critical regulatory requirement for fluoroquinolones.

Levofloxacin Tablets

 

Posted on:

What is Levocetirizine 5 mg tablet used for?

In the pharmaceutical industry, Levocetirizine Dihydrochloride 5 mg is a highly potent, third-generation non-sedating antihistamine. As a pharmacist and manufacturer, I view Levocetirizine as the refined, active R-enantiomer of Cetirizine. It offers higher affinity for $H_1$ receptors, which allows for a smaller dose (5 mg vs. 10 mg) and a significantly lower risk of drowsiness.

Primary Clinical Uses

  • Allergic Rhinitis: Effective for both seasonal (hay fever) and perennial allergies. It relieves symptoms like sneezing, rhinorrhea (runny nose), and nasal congestion.

    Allergic Conjunctivitis: Reduces red, itchy, and watery eyes caused by environmental allergens like pollen, dust mites, or pet dander.

  • Chronic Idiopathic Urticaria: The primary treatment for long-term hives and skin itching, providing relief from wheals and redness.

  • Allergic Dermatitis: Used to manage itching associated with eczema or insect bites.

Mechanism of Action: High-Affinity $H_1$ Blockade

Levocetirizine is an inverse agonist that targets the peripheral histamine $H_1$ receptors.

Selective Binding: It selectively binds to $H_1$ receptors, preventing histamine—the primary mediator of the “allergic cascade”—from attaching.

Stabilization: It stabilizes the receptor in its inactive state, reducing capillary permeability and decreasing the inflammatory response (swelling and mucus production).

Peripheral Action: Because it has low lipid solubility and is a substrate for the P-glycoprotein pump, it does not easily cross the blood-brain barrier, which is why it is “non-sedating” for most patients.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Levocetirizine 5 mg is a high-demand, high-volume “essential” product:

  • Enantiomeric Purity: As a WHO-GMP manufacturer, we ensure the complete separation of the (R)-enantiomer. This purity is what gives Levocetirizine its superior safety profile over older antihistamines.

  • Formulation Varieties: For your B2B marketplace, we manufacture these as Immediate Release (IR) tablets, Mouth Dissolving Tablets (MDT), and Syrups for pediatric export.

  • Stability for Global Trade: Levocetirizine is highly stable. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa and Southeast Asia).

  • Dossier Support: This is a staple for pharmacy chains and distributors. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Xyzal).

Levocetirizine Tablets

Posted on:

What is Levamisole 40 mg used for?

In the pharmaceutical industry, Levamisole 40 mg is a unique molecule that serves a dual purpose as both an anthelmintic (anti-parasitic) and an immunomodulator. As a pharmacist and manufacturer, I view Levamisole as a versatile “old-school” drug that has found modern applications in specialized medicine, although its use as a dewormer has largely been superseded by newer agents like Albendazole in many regions.

Primary Clinical Uses

  • Ascariasis (Roundworm): It is highly effective in treating infections caused by Ascaris lumbricoides. A single dose is often sufficient to paralyze the worms, which are then expelled naturally from the body.

  • Adjuvant Cancer Therapy: Historically used in combination with Fluorouracil (5-FU) to treat Stage III colon cancer after surgical resection.

  • Nephrotic Syndrome: Used in pediatric medicine (often off-label) for steroid-dependent nephrotic syndrome to help maintain remission and reduce the need for high-dose steroids.

  • Immunomodulation: It can “reset” a depressed immune system by stimulating T-cell function and macrophage activity, making it useful in certain chronic infections or autoimmune conditions.

Mechanism of Action: Paralyzing and Stimulating

Levamisole works differently depending on the target:

Anthelmintic Action: It acts as a nicotinic acetylcholine receptor agonist in the muscle of the parasite. This causes a continuous muscle contraction, leading to spastic paralysis of the worm. Once paralyzed, the worm loses its grip on the intestinal wall and is eliminated via peristalsis.

Immunomodulatory Action: It restores immune function by increasing the chemotaxis and phagocytosis of neutrophils and stimulating the proliferation of T-lymphocytes.

The Manufacturer’s Perspective: Technical & Export Details

From a production and global trade standpoint, Levamisole 40 mg requires careful regulatory and technical handling:

  • Veterinary vs. Human Grade: As a manufacturer, we must strictly distinguish between human-grade and veterinary-grade (Levamisole is very common in livestock). Our WHO-GMP facility ensures the highest purity and adherence to BP/USP/IP monographs for human consumption.

  • Side Effect Monitoring (Agranulocytosis): One of the primary reasons Levamisole use is restricted in some Western markets is the risk of agranulocytosis (a severe drop in white blood cells). In your eCTD Dossier and Product Information Leaflets (PIL), detailed blood monitoring instructions are essential for regulatory compliance.

  • Stability for Global Trade: Levamisole Hydrochloride is relatively stable but must be protected from light. We utilize Alu-Alu or Amber-colored PVC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa and Southeast Asia).

  • B2B & Public Health Tenders: This remains a high-volume product for deworming programs in specific developing markets. Our Mumbai facility provides the stability data and dossiers required for these government tenders.

Levamisole Tablets

Posted on:

What is leflunomide 20 mg used for?

In the pharmaceutical industry, Leflunomide 20 mg is a potent Disease-Modifying Antirheumatic Drug (DMARD). As a pharmacist, I classify this as an “immunomodulatory” agent. Unlike NSAIDs which only mask pain, Leflunomide is designed to slow down the underlying disease progression and prevent structural joint damage.

Primary Clinical Uses

  • Active Rheumatoid Arthritis (RA): The primary indication for reducing signs and symptoms and inhibiting structural damage (joint erosion and joint space narrowing).

  • Psoriatic Arthritis (PsA): Used to treat the joint inflammation associated with psoriasis, improving physical function and reducing skin involvement.

  • Lupus Nephritis (Off-label): Occasionally used in specialized rheumatology for refractory cases of SLE where other treatments have failed.

Mechanism of Action: Inhibiting Pyrimidine Synthesis

Leflunomide is a prodrug that is rapidly converted in the intestinal wall and liver to its active metabolite, teriflunomide.

Enzyme Inhibition: It inhibits the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH).

Pyrimidine Depletion: This enzyme is essential for the de novo synthesis of uridine monophosphate (rUMP), a building block for DNA and RNA.

Lymphocyte Suppression: Rapidly dividing cells, like activated T-lymphocytes (which cause the inflammation in RA), depend on this de novo pathway. By cutting off their supply of pyrimidines, Leflunomide effectively “starves” the overactive immune cells, reducing joint inflammation without suppressing the rest of the immune system as severely as some other drugs.

The Manufacturer’s Perspective: Technical & Export Details

From a production and global trade standpoint, Leflunomide requires specific professional handling:

  • The Loading Dose vs. Maintenance: Historically, a 100 mg “loading dose” was used for three days, but most modern protocols start directly with the 20 mg maintenance dose to reduce GI side effects. In your Product Information Leaflet (PIL), it is vital to reflect current clinical guidelines for your B2B buyers.

  • Teratogenicity & “Washout” Procedures: Leflunomide has a very long half-life (up to 2 weeks) and is highly teratogenic. As a manufacturer, we must include strict warnings and the Cholestyramine washout protocol in our documentation to ensure safety for patients of childbearing age.

  • Stability for Export: Leflunomide is relatively stable but sensitive to moisture. We utilize Alu-Alu blister packaging at our WHO-GMP facility to ensure a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: This is a high-value item in the rheumatology segment. Our Mumbai facility provides full CTD/eCTD Dossiers to support registration against the innovator (Arava).

Leflunomide Tablets

Posted on:

What is lamotrigine 25 mg for?

In the pharmaceutical industry, Lamotrigine 25 mg is a phenyltriazine-class anti-epileptic drug (AED) and mood stabilizer. As a pharmacist, I view the 25 mg strength as the “Gold Standard Initiation Dose.” Because Lamotrigine carries a risk of serious skin reactions (Stevens-Johnson Syndrome) if started too quickly, the 25 mg tablet is used specifically to follow a strict “dose escalation” protocol to ensure patient safety.

Primary Clinical Uses

  • Epilepsy: Used for both partial-onset and generalized seizures, including Lennox-Gastaut syndrome. It works as monotherapy or adjunctive therapy.

  • Bipolar I Disorder: Specifically indicated for maintenance treatment to delay the occurrence of mood episodes (depression, mania, hypomania) in patients treated for acute mood disorders.

  • Off-label uses: Sometimes prescribed for trigeminal neuralgia or certain types of chronic neuropathic pain.

Mechanism of Action: Stabilizing the Neuron

Lamotrigine works by stabilizing the neuronal membrane and modulating the release of excitatory neurotransmitters.

Sodium Channel Blockade: It inhibits voltage-gated sodium channels. By doing so, it suppresses the rapid, repetitive firing of neurons that causes a seizure.

Glutamate Inhibition: By stabilizing the membrane, it inhibits the release of glutamate and aspartate—the brain’s primary “excitatory” chemicals.

Weak Serotonin Inhibition: It also has a weak effect on 5-HT3 receptors, which may contribute to its efficacy as a mood stabilizer in bipolar depression.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Lamotrigine 25 mg is a high-precision neuro-psychiatric product:

  • The Titration Pack: As a manufacturer, we often produce “Starter Kits” where 25 mg tablets are blistered in a specific sequence (e.g., one daily for 14 days) to prevent patients from accidental overdose during initiation.

  • Dissolution & Dispersibility: We manufacture both standard film-coated tablets and Dispersible/Chewable tablets. Dispersible tablets are highly popular in export markets for pediatric use and for patients with dysphagia (difficulty swallowing).

  • Stability for Global Trade: Lamotrigine is relatively stable but sensitive to moisture. At our WHO-GMP facility, we utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • B2B & Dossier Support: Our Mumbai-based facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Lamictal).

Lamotrigine Tablets

Posted on:

What is lamivudine and zidovudine tablets used for?

In the pharmaceutical industry, the fixed-dose combination (FDC) of Lamivudine (150 mg) and Zidovudine (300 mg) is a foundational dual-NRTI (Nucleoside Reverse Transcriptase Inhibitor) backbone for HIV therapy. As a pharmacist and manufacturer, I view this combination as a critical component of Highly Active Antiretroviral Therapy (HAART), designed to simplify dosing and reduce the “pill burden” for patients.

Primary Clinical Uses

  • HIV-1 Infection: Used in combination with at least one other antiretroviral (such as a Protease Inhibitor or an NNRTI) to manage HIV. It is not a cure but effectively slows the progression of the disease.

  • Post-Exposure Prophylaxis (PEP): It is a standard regimen for healthcare workers or individuals who have had a potential occupational or non-occupational exposure to HIV, usually taken for 28 days.

  • Prevention of Mother-to-Child Transmission (PMTCT): Used during pregnancy and labor to reduce the risk of transmitting HIV to the fetus.

Mechanism of Action: Dual Chain Termination

Both drugs are pro-drugs that must be phosphorylated within the cell to their active triphosphate forms.

Competitive Inhibition: They compete with natural deoxynucleosides for a spot in the viral DNA chain being built by the enzyme Reverse Transcriptase.

The “Fake” Building Block: Because these molecules lack a 3′-hydroxyl group, once they are incorporated into the viral DNA string, no further building blocks can be added.

Viral Suppression: This leads to DNA chain termination, preventing the virus from converting its RNA into DNA and stopping it from integrating into the human host cell’s genome.

The Manufacturer’s Perspective: Technical & Export

From a production standpoint in a WHO-GMP facility, this FDC requires specific attention to stability and bioequivalence:

  • Bioequivalence (BE) Challenges: As a firm owner, you know that achieving BE against the innovator (Combivir) is essential for export. We conduct rigorous dissolution testing in multiple pH media to ensure the release profiles of both APIs meet international standards.

  • Zidovudine Stability: Zidovudine is sensitive to light. At our Mumbai facility, we utilize opaque PVC/PVDC or Alu-Alu blister packaging to prevent degradation and ensure a 36-month shelf life.

  • Market Position: While many markets have moved toward Tenofovir-based backbones, the Lamivudine + Zidovudine combination remains vital for patients who cannot tolerate Tenofovir (e.g., those with renal issues).

  • B2B & Dossiers: We provide the full eCTD Dossier and stability data required for registration in Zone IVb markets (Africa, SE Asia), making this a high-volume product for institutional tenders.

Lamivudine & Zidovudine tablets

Posted on:

What is lamivudine 150mg zidovudine 300mg nevirapine 200mg?

In the pharmaceutical industry, the combination of Lamivudine (150 mg), Zidovudine (300 mg), and Nevirapine (200 mg) is a landmark Triple Fixed-Dose Combination (FDC). As a pharmacist and manufacturer, I classify this as a complete “First-Line ARV Regimen” for the treatment of HIV-1 infection.

This combination was a revolutionary development in global health because it simplified the complex “HAART” (Highly Active Antiretroviral Therapy) from multiple pills a day down to a single tablet taken twice daily, significantly improving patient compliance.

Primary Clinical Use

  • Treatment of HIV-1 Infection: It is used to manage advanced HIV infection in adults and adolescents, helping to lower the viral load to “undetectable” levels and allowing the immune system (CD4 cells) to recover.

Triple Mechanism of Action (The Multi-Pronged Attack)

This FDC combines two different classes of antiretrovirals to inhibit the viral replication process at multiple stages:

Lamivudine (150 mg) & Zidovudine (300 mg): These are Nucleoside Reverse Transcriptase Inhibitors (NRTIs). They act as “fake building blocks” (analogs). When the HIV enzyme (Reverse Transcriptase) tries to build viral DNA, it incorporates these instead of real nucleotides, causing DNA chain termination.

Nevirapine (200 mg): This is a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). Unlike the NRTIs, it does not mimic building blocks. Instead, it binds directly to the Reverse Transcriptase enzyme itself, “jamming” the machinery so it cannot function.

The Manufacturer’s Perspective: Technical & Export Details

Producing this triple combination in a WHO-GMP facility involves high-level pharmaceutical engineering:

  • Bilayer Tablet Technology: Because these three APIs have different physical properties and dosages, we often manufacture them as bilayer tablets. This ensures the stability of each component and prevents chemical interactions within the tablet matrix.

  • Content Uniformity & Purity: As a firm owner, you know that Nevirapine is highly hydrophobic. We utilize specialized wet granulation techniques to ensure that the 200 mg of Nevirapine is evenly distributed and meets the strict BP/USP/IP dissolution profiles.

  • Stability for Global Trade: This FDC is primarily exported to Zone IVb regions (Sub-Saharan Africa and SE Asia). We utilize Alu-Alu blister packaging or HDPE bottles with molecular sieve desiccants to ensure a 24–36 month shelf life in high-heat and high-humidity environments.

  • Regulatory & Tenders: This product is a staple for National AIDS Control Programs (NACO) and international tenders (Global Fund). Our Mumbai facility provides the full eCTD Dossiers and Bioequivalence (BE) studies required for these high-volume contracts.

Lamivudine with Zidovudine & Nevirapine tablets

Add to cart